Generation Bio is a biotechnology company changing what is possible for people living with T cell-driven autoimmune diseases. The company is developing novel therapeutics leveraging its T cell selective cell-targeted lipid nanoparticle (ctLNP) to deliver siRNA in vivo, enabling modulation of T cell activity that causes inflammation and auto-reactive tissue destruction. By selectively modulating T cells that drive disease pathology, ctLNP-siRNA th...
SUMMARY. Generation Bio is seeking an energetic and motivated Principal Scientist with experience and technical expertise building siRNA-based therapies. The successful candidate will lead design approaches for optimizing siRNA cargo, through both molecular and chemical intervention. As part of this effort, the Principal Scientist will help build the core infrastructure required for iterative design and evaluation of siRNA molecules to drive prog...
